Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency

NCT04295733 · clinicaltrials.gov ↗

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Acquired Immunodeficiency

Interventions

BIOLOGICAL: 4CMenB (Bexsero®) vaccine

Sponsor

Ospedale Policlinico San Martino

Collaborators

[object Object]